Guillain–Barré syndrome | Rapidly progressive ascending weakness |
May involve respiratory muscles |
Loss of reflexes |
May have severe back pain |
Respiratory or gastrointestinal illness two to four weeks prior to onset |
Botulism | Symmetric descending weakness |
Wound botulism | Cranial nerve weakness—for example, diplopia |
Food borne botulism | No sensory symptoms |
| Prodromal nausea, vomiting, diarrhoea |
| Suspect in intravenous drug users |
Spinal cord disease | Back pain |
Sensory level |
Sphincter disturbance |
Motor neurone disease | Progressive weakness over months |
Fasciculation of muscles |
Exaggerated reflexes |
May have bulbar involvement |
Vasculitic neuropathy | Painful |
Multiple peripheral nerves affected (mononeuritis multiplex) |
Raised inflammatory markers |
May be associated with rash, arthropathy, renal disease |
Myasthenia gravis | Bulbar, ocular, and respiratory muscles affected |
Ptosis |
Fatigability |
Viral myositis | Painful muscles |
Raised creatine kinase |
Drug induced myopathy | Progressive proximal weakness over weeks |
Myalgia |
Drugs history—for example, statins |
Metabolic disorders | Alcoholism |
Hypokalaemia | Anorexia |
Hypomagnesaemia | Drugs—for example, laxatives, diuretics |
Hypophosphataemia | |
Polymyalgia rheumatica | Elderly patient |
Proximal pain and weakness |
Malaise |
May be associated with weight loss, headache, |
Raised ESR |